Selective Serotonin Reuptake Inhibitor
Showing 51 - 75 of >10,000
Therapeutic Mechanism of Antidepressants for Refractory FD Trial in Hangzhou (selective serotonin reuptake inhibitor (SSRI) or
Unknown status
- Therapeutic Mechanism of Antidepressants for Refractory FD
- selective serotonin reuptake inhibitor (SSRI) or serotonin noradrenaline reuptake inhibitor (SNRI) antidepressants
- conventional therapy
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Jun 2, 2019
Stress Urinary Incontinence, Fecal Incontinence Trial in Copenhagen (Citalopram 40mg, Reboxetine 8 mg, Placebo oral tablet)
Completed
- Stress Urinary Incontinence
- Fecal Incontinence
- Citalopram 40mg
- +2 more
-
Copenhagen, DenmarkDepartment of Clinical Pharmacology, Bispebjerg and Frederiksber
Jun 8, 2021
MDDs Trial in Tianjin (N-acetylcysteine, comparator of N-acetylcysteine)
Recruiting
- Major Depressive Disorders
- N-acetylcysteine
- placebo comparator of N-acetylcysteine
-
Tianjin, Tianjin, ChinaTianjin Anding Hospital
Sep 21, 2022
Depressive Disorder Trial in Tanta (Fluoxetine 20 mg, Dapagliflozin 10mg Tab, Atorvastatin 80mg)
Not yet recruiting
- Depressive Disorder
- Fluoxetine 20 mg
- +2 more
-
Tanta, Shebeen El-Kom, EgyptFaculty of Medicine, Menoufia University
Mar 19, 2023
Nocturnal Enuresis Trial in Mansoura (Fluoxetine, Placebo)
Unknown status
- Nocturnal Enuresis
- Fluoxetine
- Placebo
-
Mansoura, Dakahlia, EgyptMansoura urology and nephrology center
Dec 15, 2020
Success of Inferior Alveolar Nerve Block in Women Taking
Completed
- Local Anesthesia
- selective serotonin reuptake inhibitor
-
Isfahan, Iran, Islamic Republic ofSchool of Dentistry, Isfahan University of Medical Sciences
Feb 11, 2019
MDD Trial in Erbil (Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg, Citalopram (tablet) 20 mg + Placebo (tablet))
Completed
- Major Depressive Disorder
- Citalopram (tablet) 20 mg + Pentoxifylline (tablet) 400Mg
- Citalopram (tablet) 20 mg + Placebo (tablet)
-
Erbil, IraqHawler Psychiatric Hospital and Private Clinic
Mar 16, 2022
Depression Trial in Winston-Salem (Fluoxetine 20 MG, Duloxetine 30 MG, Observation)
Not yet recruiting
- Depression
- Fluoxetine 20 MG
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 28, 2023
Tamoxifen in Breast Cancer and in Women at High-Risk of Breast
Active, not recruiting
- Breast Cancer
- +3 more
- citalopram hydrobromide
- +10 more
-
Indianapolis, Indiana
- +3 more
Feb 18, 2022
PTSD Trial in Boston (LDAEP, Placebo, sertraline)
Recruiting
- Posttraumatic Stress Disorder
- LDAEP
- +2 more
-
Boston, MassachusettsVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Mar 9, 2022
Healthy Young and Older Adults Trial in Berlin (procedure, drug, other)
Completed
- Healthy Young and Older Adults
- tDCS
- +2 more
-
Berlin, GermanyCharite Universitätsmedizin Berlin
May 10, 2021
Depression, Depressive Disorder Trial in Bhopal (Healthy Activity Program (HAP), Antidepressant medication (ADM))
Recruiting
- Depression
- Depressive Disorder
- Healthy Activity Program (HAP)
- Antidepressant medication (ADM)
-
Bhopal, Madhya Pradesh, IndiaSangath
Nov 22, 2023
Acute Stroke, Visual Field Loss Trial in Rochester (Fluoxetine, Placebo)
Terminated
- Acute Stroke
- Visual Field Loss
- Fluoxetine
- Placebo
-
Rochester, New YorkStrong Memorial Hospital
Sep 16, 2021
Sexual Dysfunction Trial in Newport Beach (Viveve System)
Unknown status
- Sexual Dysfunction
- Viveve System
-
Newport Beach, CaliforniaSouthern California Center for Sexual Health and Survivorship Me
Nov 19, 2018
MDD Trial in Taichung (NMDAE, Sertraline, Placebo Cap)
Recruiting
- Major Depressive Disorder
- NMDAE
- +2 more
-
Taichung, TaiwanDepartment of Psychiatry, China Medical University Hospital
Nov 16, 2021
OCD, EEG With Periodic Abnormalities Trial in Istanbul (Deep Transcranial Magnetic Stimulation, Paroxetine)
Active, not recruiting
- Obsessive-Compulsive Disorder
- EEG With Periodic Abnormalities
- Deep Transcranial Magnetic Stimulation
- Paroxetine
-
Istanbul, Beykoz, TurkeyIstanbul Medipol University
Dec 26, 2021
Hospital Mobility, Mobility Limitation, Life-Space Trial in Villars-sur-Glâne, Bern (INTOMOB intervention)
Recruiting
- Hospital Mobility
- +7 more
- INTOMOB intervention
-
Villars-sur-Glâne, Fribourg, Switzerland
- +2 more
Dec 19, 2022
Dyspepsia, Anxiety, Depression Trial in Hong Kong (Escitalopram, Placebo)
Completed
- Dyspepsia
- +2 more
- Escitalopram
- Placebo
-
Hong Kong, Hong KongPrince of Wales Hospital
Jan 30, 2019
MDD Trial in Dhaka (SSRI with Zinc Sulfate)
Completed
- MDD
- SSRI with Zinc Sulfate
-
Dhaka, BangladeshBSMMU
Jan 26, 2021
OCD Trial in Hamilton (SSRIs)
Completed
- Obsessive-Compulsive Disorder
-
Hamilton, Ontario, CanadaMacAnxiety Research Centre
Aug 31, 2020
Parkinson Disease Trial in Ann Arbor (Citalopram 20mg, Placebo)
Recruiting
- Parkinson Disease
- Citalopram 20mg
- Placebo
-
Ann Arbor, MichiganUniversity of Michigan
Mar 30, 2022
Depression, Unipolar, PTSD, Trauma Trial in Kisumu (Fluoxetine, Interpersonal Psychotherapy)
Active, not recruiting
- Depression, Unipolar
- +2 more
- Fluoxetine
- Interpersonal Psychotherapy
-
Kisumu, Kenya
- +2 more
Oct 31, 2022
Anxiety, Separation, Anxiety, Generalized, Anxiety, Social Trial in Los Angeles, Chicago, Cincinnati (Cognitive Behavioral
Recruiting
- Anxiety, Separation
- +2 more
- Cognitive Behavioral Therapy (CBT)
- Combination therapy (COMB)
-
Los Angeles, California
- +2 more
Sep 1, 2021
MDD Trial in Shanghai (SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors),
Not yet recruiting
- Major Depressive Disorder
- SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
- +2 more
-
Shanghai, Shanghai, China
- +3 more
Aug 24, 2020
Uremic Pruritis Trial in Alexandria (sertraline, )
Completed
- Uremic Pruritis
- sertraline
- placebo
-
Alexandria, EgyptFaculty of Medicine, Aexandria University
Dec 12, 2022